These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
254 related articles for article (PubMed ID: 7820070)
1. Irreversible blockade of D2 dopamine receptors by fluphenazine-N-mustard increases D2 dopamine receptor mRNA and proenkephalin mRNA and decreases D1 dopamine receptor mRNA and mu and delta opioid receptors in rat striatum. Chen JF; Aloyo VJ; Qin ZH; Weiss B Neurochem Int; 1994 Oct; 25(4):355-66. PubMed ID: 7820070 [TBL] [Abstract][Full Text] [Related]
2. Continuous treatment with the D2 dopamine receptor agonist quinpirole decreases D2 dopamine receptors, D2 dopamine receptor messenger RNA and proenkephalin messenger RNA, and increases mu opioid receptors in mouse striatum. Chen JF; Aloyo VJ; Weiss B Neuroscience; 1993 Jun; 54(3):669-80. PubMed ID: 8101360 [TBL] [Abstract][Full Text] [Related]
3. Continuous infusion of clozapine increases mu and delta opioid receptors and proenkephalin mRNA in mouse brain. Zhang SP; Connell TA; Price T; Simpson GM; Zhou LW; Weiss B Biol Psychiatry; 1995 Apr; 37(8):496-503. PubMed ID: 7619972 [TBL] [Abstract][Full Text] [Related]
4. Involvement of dopamine D1 and D2 receptors in the regulation of proenkephalin mRNA abundance in the striatum and accumbens of the rat brain. Angulo JA J Neurochem; 1992 Mar; 58(3):1104-9. PubMed ID: 1346626 [TBL] [Abstract][Full Text] [Related]
5. Irreversible blockade of D2 dopamine receptors by fluphenazine-N-mustard increases glutamic acid decarboxylase mRNA in rat striatum. Chen JF; Weiss B Neurosci Lett; 1993 Feb; 150(2):215-8. PubMed ID: 8097031 [TBL] [Abstract][Full Text] [Related]
6. Proenkephalin mRNA levels in rat striatum are increased and decreased, respectively, by selective D2 and D1 dopamine receptor antagonists. Morris BJ; Hunt SP Neurosci Lett; 1991 Apr; 125(2):201-4. PubMed ID: 1831887 [TBL] [Abstract][Full Text] [Related]
7. D2 dopamine receptor messenger RNA is altered to a greater extent by blockade of glutamate receptors than by blockade of dopamine receptors. Qin ZH; Zhou LW; Weiss B Neuroscience; 1994 May; 60(1):97-114. PubMed ID: 8052421 [TBL] [Abstract][Full Text] [Related]
8. Specific reductions of striatal prodynorphin and D1 dopamine receptor messenger RNAs during cocaine abstinence. Svensson P; Hurd YL Brain Res Mol Brain Res; 1998 May; 56(1-2):162-8. PubMed ID: 9602109 [TBL] [Abstract][Full Text] [Related]
9. Chronic morphine exposure and spontaneous withdrawal are associated with modifications of dopamine receptor and neuropeptide gene expression in the rat striatum. Georges F; Stinus L; Bloch B; Le Moine C Eur J Neurosci; 1999 Feb; 11(2):481-90. PubMed ID: 10051749 [TBL] [Abstract][Full Text] [Related]
10. Differential effects of fluphenazine-N-mustard, on calmodulin activity and on D1 and D2 dopaminergic responses. Winkler JD; Thermos K; Weiss B Psychopharmacology (Berl); 1987; 92(3):285-91. PubMed ID: 2957717 [TBL] [Abstract][Full Text] [Related]
13. Regional distribution and regulation of preprosomatostatin messenger RNA in the striatum, as revealed by in situ hybridization histochemistry. Weiss LT; Chesselet MF Brain Res Mol Brain Res; 1989 Mar; 5(2):121-30. PubMed ID: 2566104 [TBL] [Abstract][Full Text] [Related]
14. Phenotypical characterization of the neurons expressing the D1 and D2 dopamine receptors in the monkey striatum. Aubert I; Ghorayeb I; Normand E; Bloch B J Comp Neurol; 2000 Feb; 418(1):22-32. PubMed ID: 10701753 [TBL] [Abstract][Full Text] [Related]
15. Dopaminergic and glutamatergic blocking drugs differentially regulate glutamic acid decarboxylase mRNA in mouse brain. Qin ZH; Zhang SP; Weiss B Brain Res Mol Brain Res; 1994 Feb; 21(3-4):293-302. PubMed ID: 8170353 [TBL] [Abstract][Full Text] [Related]
16. Parallel decrease of glutamic acid decarboxylase and preproenkephalin mRNA in the rat striatum following chronic treatment with a dopaminergic D1 antagonist and D2 agonist. Caboche J; Vernier P; Julien JF; Rogard M; Mallet J; Besson MJ J Neurochem; 1991 Feb; 56(2):428-35. PubMed ID: 1824860 [TBL] [Abstract][Full Text] [Related]
17. Lesions of mouse striatum induced by 6-hydroxydopamine differentially alter the density, rate of synthesis, and level of gene expression of D1 and D2 dopamine receptors. Qin ZH; Chen JF; Weiss B J Neurochem; 1994 Feb; 62(2):411-20. PubMed ID: 8294904 [TBL] [Abstract][Full Text] [Related]
18. D2 dopamine receptor antisense oligodeoxynucleotide inhibits the synthesis of a functional pool of D2 dopamine receptors. Qin ZH; Zhou LW; Zhang SP; Wang Y; Weiss B Mol Pharmacol; 1995 Oct; 48(4):730-7. PubMed ID: 7476901 [TBL] [Abstract][Full Text] [Related]
19. Cocaine-induced mu opioid receptor occupancy within the striatum is mediated by dopamine D2 receptors. Soderman AR; Unterwald EM Brain Res; 2009 Nov; 1296():63-71. PubMed ID: 19699185 [TBL] [Abstract][Full Text] [Related]
20. Quantitative in situ hybridization evidence for differential regulation of proenkephalin and dopamine D2 receptor mRNA levels in the rat striatum: effects of unilateral intrastriatal injections of 6-hydroxydopamine. Cadet JL; Zhu SM; Angulo JA Brain Res Mol Brain Res; 1992 Jan; 12(1-3):59-67. PubMed ID: 1312206 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]